ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 796 - 810 of 5996 products
CellOrigin and Qilu to Develop Off-the-Shelf CAR-Macrophage Immunotherapies
$5.00
Available
CASI and BioInvent Start China Trial of FcγRIIB Inhibitor for NHL
$5.00
Available
BoomRay Raises $43 Million for Novel Diagnostic/Therapeutic Radionuclide Medicines
$5.00
Available
Vernalis Collaborates with Unison to Discover Drugs for “Undruggable” Bacterial Target
$5.00
Available
Neukio Bio Completes $50 Million Round for Allogenic CAR-T Therapies
$5.00
Available
DAC Biotech to Discover Five ADCs in Partnership with Janssen Biotech
$5.00
Available
Hangzhou Innoforce and Hibiscus Join to Advance Mayo Clinic’s Cell and Gene Therapies
$5.00
Available
E-nitiateBio Closes $15 Million Round to Support Autoimmune Portfolio
$5.00
Available
Asieris Acquires Rights to Heart Failure Therapy from Acorda
$5.00
Available
I-Mab to Concentrate on Five Clinical-Stage Candidates, Out-licensing International Rights
$5.00
Available
Sirnaomics Reports 100% Complete Response for Lead siRNA Candidate
$5.00
Available
UniCar Closes C Funding for “Safe” CAR-T Dual Target Candidate
$5.00
Available
RedCloud Doses NSCLC Patient in China Trial of Next-Gen EGFR TK
$5.00
Available
Bao Pharma Raises $100 Million in Series B Round for Protein/Antibody Drugs
$5.00
Available
Bao Pharma Raises $100 Million in Series B Round for Protein/Antibody Drugs
$5.00
Available